CoChat
Sign Up
Cited by 64

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells

Trocoli, A, Bensadoun, P, Richard, E, Labrunie, G, Merhi, F, Schläfli, A M, Brigger, D, Souquere, S, Pierron, G, Pasquet, J-M, Soubeyran, P, Reiffers, J, Ségal-Bendirdjian, E, Tschan, M P, Djavaheri-Mergny, M·2014·Cell Death & Differentiation
DOI 10.1038/cdd.2014.102
Open this paper in CoChat — free account

Abstract

The p62/SQSTM1 adapter protein has an important role in the regulation of several key signaling pathways and helps transport ubiquitinated proteins to the autophagosomes and proteasome for degradation. Here, we investigate the regulation and roles of p62/SQSTM1 during acute myeloid leukemia (AML) cell maturation into granulocytes. Levels of p62/SQSTM1 mRNA and protein were both significantly increased during all-trans retinoic acid (ATRA)-induced differentiation of AML cells through a mechanism that depends on NF-κB activation. We show that this response constitutes a survival mechanism that prolongs the life span of mature AML cells and mitigates the effects of accumulation of aggregated proteins that occurs during granulocytic differentiation. Interestingly, ATRA-induced p62/SQSTM1 upregulation was impaired in maturation-resistant AML cells but was reactivated when differentiation was restored in these cells. Primary blast cells of AML patients and CD34(+) progenitors exhibited significantly lower p62/SQSTM1 mRNA levels than did mature granulocytes from healthy donors. Our results demonstrate that p62/SQSTM1 expression is upregulated in mature compared with immature myeloid cells and reveal a pro-survival function of the NF-κB/SQSTM1 signaling axis during granulocytic differentiation of AML cells. These findings may help our understanding of neutrophil/granulocyte development and will guide the development of novel therapeutic strategies for refractory and relapsed AML pati…

Overview

Integrity signals

Registry

Crossref · 10.1038/cdd.2014.102

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 55

  1. Komatsu M, Kageyama S, Ichimura Y . p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 2012; 66: 457–462. · DOI
  2. Geetha T, Vishwaprakash N, Sycheva M, Babu JR . Sequestosome 1/p62: across diseases. Biomarkers 2012; 17: 99–103. · DOI
  3. Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA, Moscat J . The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J Biol Chem 2001; 276: 7709–7712. · DOI
  4. Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 2011; 44: 134–146. · DOI · Paper page
  5. Nezis IP, Stenmark H . p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid Redox Signal 2012; 17: 786–793. · DOI
  6. Puissant A, Fenouille N, Auberger P . When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2012; 2: 397–413.
  7. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282: 24131–24145. · DOI · Paper page
  8. Lin X, Li S, Zhao Y, Ma X, Zhang K, He X et al. Interaction domains of p62: A bridge between p62 and selective autophagy. DNA Cell Biol 2013; 32: 220–227. · DOI
  9. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 1062–1075. · DOI
  10. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213–223. · DOI · Paper page
  11. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 2010; 30: 3275–3285. · DOI
  12. Goussetis DJ, Gounaris E, Wu EJ, Vakana E, Sharma B, Bogyo M et al. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood 2012; 120: 3555–3562. · DOI
  13. Petherick KJ, Williams AC, Lane JD, Ordonez-Moran P, Huelsken J, Collard TJ et al. Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J 2013; 32: 1903–1916. · DOI
  14. Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T et al. Autophagy negatively regulates Wnt signalling by promoting dishevelled degradation. Nat Cell Biol 2010; 12: 781–790. · DOI
  15. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009; 137: 721–735. · DOI
  16. Young MM, Takahashi Y, Khan O, Park S, Hori T, Yun J et al. Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem 2012; 287: 12455–12468. · DOI
  17. Lee SJ, Pfluger PT, Kim JY, Nogueiras R, Duran A, Pages G et al. A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep 2010; 11: 226–232. · DOI
  18. Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 2004; 6: 303–309. · DOI · Paper page
  19. Waters S, Marchbank K, Solomon E, Whitehouse CA . Autophagic receptors Nbr1 and p62 coregulate skeletal remodeling. Autophagy 2010; 6: 981–983. · DOI
  20. Samuels IS, Seibenhener ML, Neidigh KB, Wooten MW . Nerve growth factor stimulates the interaction of ZIP/p62 with atypical protein kinase C and targets endosomal localization: evidence for regulation of nerve growth factor-induced differentiation. J Cell Biochem 2001; 82: 452–466. · DOI
  21. Colosetti P, Puissant A, Robert G, Luciano F, Jacquel A, Gounon P et al. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line. Autophagy 2009; 5: 1092–1098. · DOI · Paper page
  22. Chang CP, Su YC, Hu CW, Lei HY . TLR2-dependent selective autophagy regulates NF-kappaB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell Death Differ 2013; 20: 515–523. · DOI
  23. Licht JD . Acute promyelocytic leukemia—weapons of mass differentiation. N Engl J Med 2009; 360: 928–930. · DOI
  24. Becker H, Bloomfield CD . Acute myeloid leukaemia in 2012: En route to improved treatment options. Nat Rev Clin Oncol 2013; 10: 76–79. · DOI
  25. de The H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561. · DOI
  26. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM . A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333–343. · DOI
  27. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572. · DOI
  28. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709. · DOI
  29. Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z . How to manage acute promyelocytic leukemia. Leukemia 2012; 26: 1743–1751. · DOI
  30. Gallagher RE . Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 2002; 16: 1940–1958. · DOI
  31. Petrie K, Zelent A, Waxman S . Differentiation therapy of acute myeloid leukemia: past, present and future. Curr Opin Hematol 2009; 16: 84–91. · DOI
  32. Kamimura T, Miyamoto T, Harada M, Akashi K . Advances in therapies for acute promyelocytic leukemia. Cancer Sci 2011; 102: 1929–1937. · DOI
  33. Trocoli A, Mathieu J, Priault M, Reiffers J, Souquere S, Pierron G et al. ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells. Autophagy 2011; 7: 1108–1114. · DOI · Paper page
  34. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R . NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080–1086. · DOI
  35. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner P et al. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. Leukemia 1992; 6: 1281–1287.
  36. Zhao Q, Tao J, Zhu Q, Jia PM, Dou AX, Li X et al. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation. Leukemia 2004; 18: 285–292. · DOI
  37. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57–74. · DOI · Paper page
  38. Mathieu J, Giraudier S, Lanotte M, Besancon F . Retinoid-induced activation of NF-kappaB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells. Oncogene 2005; 24: 7145–7155. · DOI
  39. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA . Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 1995; 14: 2876–2883. · DOI
  40. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002; 160: 255–263. · DOI · Paper page
  41. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW . Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004; 24: 8055–8068. · DOI
  42. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171: 603–614. · DOI · Paper page
  43. Lamark T, Kirkin V, Dikic I, Johansen T . NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009; 8: 1986–1990. · DOI · Paper page
  44. Ichimura Y, Komatsu M . Selective degradation of p62 by autophagy. Semin Immunopathol 2010; 32: 431–436. · DOI
  45. Moscat J, Diaz-Meco MT . p62: a versatile multitasker takes on cancer. Trends Biochem Sci 2012; 37: 230–236. · DOI
  46. Isakson P, Bjoras M, Boe SO, Simonsen A . Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood 2010; 116: 2324–2331. · DOI
  47. Wang Z, Cao L, Kang R, Yang M, Liu L, Zhao Y et al. Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARalpha oncoprotein. Autophagy 2011; 7: 401–411. · DOI
  48. Huang Y, Hou JK, Chen TT, Zhao XY, Yan ZW, Zhang J et al. PML-RARalpha enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway. Autophagy 2011; 7: 1132–1144. · DOI
  49. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 105–120. · DOI · Paper page
  50. Federzoni EA, Valk PJ, Torbett BE, Haferlach T, Lowenberg B, Fey MF et al. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood 2012; 119: 4963–4970. · DOI
  51. Britschgi C, Jenal M, Rizzi M, Mueller BU, Torbett BE, Andres AC et al. HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. Br J Haematol 2008; 141: 179–187. · DOI
  52. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463–8471. · DOI · Paper page
  53. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 2006; 281: 30373–30382. · DOI · Paper page
  54. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408. · DOI · Paper page
  55. Garcia-Mata R, Bebok Z, Sorscher EJ, Sztul ES . Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol 1999; 146: 1239–1254. · DOI

Cited by

Sorted by citations

See all 64

Metadata

Authors
Trocoli, A., Bensadoun, P., Richard, E., Labrunie, G., Merhi, F., Schläfli, A. M., Brigger, D., Souquere, S., Pierron, G., Pasquet, J.-M., Soubeyran, P., Reiffers, J., Ségal-Bendirdjian, E., Tschan, M. P., & Djavaheri-Mergny, M.
Venue
Cell Death & Differentiation
Publisher
Springer Science and Business Media LLC
Published
2014-07-18
Volume
21
Issue
12
Pages
1852-1861
ISSN
  • 1350-9047
  • 1476-5403
DOI
10.1038/cdd.2014.102
Cited by
64
References
3
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review